Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
17.38 GBX | -0.69% |
|
+6.95% | +12.13% |
14/06 | Renalytix's Diabetes, Kidney Disease Test Gets Medicare Final Coverage Determination | MT |
14/06 | Renalytix Secures Medicare's Final Local Coverage Determination for Kidney Disease Test | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.13% | 34.38M | |
-35.65% | 14.14B | |
-51.68% | 2.38B | |
+25.12% | 1.98B | |
-8.77% | 1.52B | |
+22.36% | 1.26B | |
-21.62% | 902M | |
-32.86% | 767M | |
-1.84% | 752M | |
-25.90% | 621M |
- Stock Market
- Equities
- RENX Stock
- News Renalytix Plc
- Renalytix Names Chief Business Officer